Breast MR imaging in women at high-risk of breast cancer. Is something changing in early breast cancer detection?
暂无分享,去创建一个
[1] P. V. van Diest,et al. BRCA1 and BRCA2 germline mutation analysis in the Indonesian population , 2007, Breast Cancer Research and Treatment.
[2] R. Fimmers,et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] Hans H Schild,et al. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution. , 2005, Radiology.
[4] H. D. de Koning,et al. Hereditary breast cancer growth rates and its impact on screening policy. , 2005, European journal of cancer.
[5] R. Eeles,et al. Too much, too soon? Patients and health professionals' views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40. , 2005, European journal of cancer care.
[6] Joan Leach,et al. Expert heads a'rolling Melissa Leach Ian , 2005, The Lancet.
[7] S. Narod,et al. Time to reconsider subcutaneous mastectomy for breast-cancer prevention? , 2005, The Lancet. Oncology.
[8] L. Esserman,et al. MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. , 2005, AJR. American journal of roentgenology.
[9] A R Padhani,et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) , 2005, The Lancet.
[10] G. Porter,et al. Ten years of breast screening in the Nova Scotia Breast Screening Program, 1991-2001. experience: use of an adaptable stereotactic device in the diagnosis of screening-detected abnormalities. , 2005, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.
[11] M. Miyazaki,et al. Pharmacokinetic analysis of ductal carcinoma in situ of the breast using dynamic MR mammography , 2005, European Radiology.
[12] J. Elmore,et al. A population-based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices. , 2005, Archives of internal medicine.
[13] F. Podo,et al. Women with history of breast cancer excluded from screening programs: is it the right choice? , 2005, Radiology.
[14] Dianne Georgian-Smith,et al. Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. , 2005, AJR. American journal of roentgenology.
[15] J. Klijn,et al. Efficacy of magnetic resonance imaging and mammography for breast cancer screening in women with a familial or genetic predisposition , 2005 .
[16] R. Calderon-Margalit,et al. Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: A critical review of the literature , 2004, International journal of cancer.
[17] Massimo Bazzocchi,et al. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in Fatty and dense breasts using the whole-breast pathologic examination as a gold standard. , 2004, AJR. American journal of roentgenology.
[18] Ellen Warner,et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination , 2004, JAMA.
[19] W. Berg. Image-guided breast biopsy and management of high-risk lesions. , 2004, Radiologic clinics of North America.
[20] C. Sewell,et al. Pathology of high-risk breast lesions and ductal carcinoma in situ. , 2004, Radiologic clinics of North America.
[21] F. Sardanelli,et al. Dynamic Breast Magnetic Resonance Imaging: Effect of Changing the Region of Interest on Early Enhancement Using 2D and 3D Techniques , 2004, Journal of computer assisted tomography.
[22] W. Berg. Supplemental screening sonography in dense breasts. , 2004, Radiologic clinics of North America.
[23] R. Bisegna,et al. Reducing breast cancer incidence in familial breast cancer: overlooking the present panorama. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[24] Christian Hintze,et al. Combination of low and high resolution sequences in two orientations for dynamic contrast-enhanced MRI of the breast: more than a compromise , 2004, European Radiology.
[25] H. D. de Koning,et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. , 2004, The New England journal of medicine.
[26] Uwe Fischer,et al. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer , 2004, European Radiology.
[27] J. Weyler,et al. Enhancing area surrounding breast carcinoma on MR mammography: comparison with pathological examination , 2004, European Radiology.
[28] A. D. De Schepper,et al. Preoperative breast MRI in patients with invasive lobular breast cancer , 2004, European Radiology.
[29] W. A. Kaiser,et al. Is the “blooming sign” a promising additional tool to determine malignancy in MR mammography? , 2004, European Radiology.
[30] V. Vogel,et al. Recognition and management of hereditary breast cancer syndromes. , 2004, The oncologist.
[31] B. Friedenson. Assessing and managing breast cancer risk: clinical tools for advising patients. , 2004, MedGenMed : Medscape general medicine.
[32] C. Kuhl,et al. Breast MR imaging during or soon after radiation therapy. , 2003, Radiology.
[33] J. Coebergh,et al. Trends in incidence of and mortality from cancer in The Netherlands in the period 1989-1998. , 2003, European journal of cancer.
[34] Elizabeth A Morris,et al. Fast MRI-guided vacuum-assisted breast biopsy: initial experience. , 2003, AJR. American journal of roentgenology.
[35] A. Fausto,et al. MR imaging of the breast: indications, established technique, and new directions , 2003, European Radiology.
[36] M Thelen,et al. Improved artificial neural networks in prediction of malignancy of lesions in contrast-enhanced MR-mammography. , 2003, Medical physics.
[37] Elizabeth A Morris,et al. MRI of occult breast carcinoma in a high-risk population. , 2003, AJR. American journal of roentgenology.
[38] Elizabeth A Morris,et al. Breast lesions detected with MR imaging: utility and histopathologic importance of identification with US. , 2003, Radiology.
[39] Elizabeth A Morris,et al. MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. , 2003, AJR. American journal of roentgenology.
[40] D. Stoppa-Lyonnet,et al. IMPACT OF GENE PATENTS ON THE COST-EFFECTIVE DELIVERY OF CARE: THE CASE OF BRCA1 GENETIC TESTING , 2003, International Journal of Technology Assessment in Health Care.
[41] B. Weber,et al. Application of breast cancer risk prediction models in clinical practice. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[42] Jennifer B Kaplan,et al. MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. , 2003, AJR. American journal of roentgenology.
[43] G. Lenoir,et al. Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. , 2002, Journal of the National Cancer Institute.
[44] T. M. Kolb,et al. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. , 2002, Radiology.
[45] C. Zuiani,et al. The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. , 2002, Journal of experimental & clinical cancer research : CR.
[46] Gordon B Mills,et al. Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. , 2002, Journal of the National Cancer Institute.
[47] P. Marano,et al. Magnetic Resonance Imaging in Breast Cancer Recurrence , 2002, Breast Cancer Research and Treatment.
[48] Susan L Neuhausen,et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. , 2002, The New England journal of medicine.
[49] J. Satagopan,et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. , 2002, The New England journal of medicine.
[50] S. Heywang-Köbrunner,et al. Suppression of Unspecific Enhancement on Breast Magnetic Resonance Imaging (Mri) by Antiestrogen Medication , 2002, Tumori.
[51] L. Liberman,et al. Preoperative MR imaging-guided needle localization of breast lesions. , 2002, AJR. American journal of roentgenology.
[52] J. Satagopan,et al. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[53] E. Grabbe,et al. Classification of hypervascularized lesions in CE MR imaging of the breast , 2002, European Radiology.
[54] P. Chappuis,et al. Re: Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. , 2001, Journal of the National Cancer Institute.
[55] S. Fosså,et al. Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors. , 2001, Journal of the National Cancer Institute.
[56] T. Walsh,et al. Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. , 2001, JAMA.
[57] T. Sellers,et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. , 2001, Journal of the National Cancer Institute.
[58] D B Plewes,et al. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[59] J. Klijn,et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. , 2001, The New England journal of medicine.
[60] D. Bowen,et al. Comparisons of two breast cancer risk estimates in women with a family history of breast cancer. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[61] J. Klijn,et al. Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[62] S. Wurdinger,et al. Comparison of written reports of mammography, sonography and magnetic resonance mammography for preoperative evaluation of breast lesions, with special emphasis on magnetic resonance mammography , 2000, Breast Cancer Research.
[63] D. Dershaw. Mammographic screening of the high-risk woman. , 2000, American journal of surgery.
[64] Matthijs Oudkerk,et al. First experiences in screening women at high risk for breast cancer with MR imaging , 2000, Breast Cancer Research and Treatment.
[65] D Krebs,et al. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. , 2000, Radiology.
[66] R. Macmillan. Screening women with a family history of breast cancer--results from the British Familial Breast Cancer Group. , 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[67] E Grabbe,et al. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. , 1999, Radiology.
[68] M H Gail,et al. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. , 1999, Journal of the National Cancer Institute.
[69] D. Fraker,et al. Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. , 1999, Radiology.
[70] C. Kuhl,et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? , 1999, Radiology.
[71] J. Thornby,et al. The Life Span of Silicone Gel Breast Implants and a Comparison of Mammography, Ultrasonography, and Magnetic Resonance Imaging in Detecting Implant Rupture: A Meta‐analysis , 1998, Annals of plastic surgery.
[72] C A Kelsey,et al. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico. , 1998, Radiology.
[73] M. Stratton,et al. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. , 1998, Journal of the National Cancer Institute.
[74] H. D. de Koning,et al. Radiation risk of mammography related to benefit in screening programmes: a favourable balance? , 1998, Journal of medical screening.
[75] A. Howell,et al. Screening by mammography, women with a family history of breast cancer. , 1998, European journal of cancer.
[76] A. Del Maschio,et al. MR state of the art. , 1998, European journal of radiology.
[77] I. Ellis,et al. Screening women aged less than 50 years with a family history of breast cancer. , 1998, European journal of cancer.
[78] L. Norton,et al. BRCA-associated breast cancer in young women. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[79] J Chang-Claude,et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.
[80] E Grabbe,et al. Magnetic Resonance Guided Localization and Biopsy of Suspicious Breast Lesions , 1998, Topics in magnetic resonance imaging : TMRI.
[81] J. Klijn,et al. Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1 , 1998, The Lancet.
[82] E. Franssen,et al. Management of women at increased risk for breast cancer: preliminary results from a new program. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[83] C K Kuhl,et al. Interventional breast MR imaging: clinical use of a stereotactic localization and biopsy device. , 1997, Radiology.
[84] M. Stratton. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases , 1997, The Lancet.
[85] A. Bowcock,et al. Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer. , 1997, The New England journal of medicine.
[86] M. King,et al. Population genetics of BRCA1 and BRCA2. , 1997, American journal of human genetics.
[87] G. Eichele,et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2 , 1997, Nature.
[88] E. Thomson,et al. Recommendations for follow-up care of individuals with an inherited predisposition to Cancer. II. BRCA1 and BRCA2 , 1997 .
[89] K Offit,et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. , 1997, JAMA.
[90] M D Schnall,et al. Breast MR imaging: interpretation model. , 1997, Radiology.
[91] P. Tonin,et al. Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes? , 1997, American journal of human genetics.
[92] S. Moss,et al. Benefits versus risks from mammography. A critical reassessment. , 1997, Cancer.
[93] A Heinig,et al. Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. , 1997, European journal of radiology.
[94] M. Schnall,et al. High-resolution MR imaging of the breast: clinical context. , 1996, Radiographics : a review publication of the Radiological Society of North America, Inc.
[95] T. Merchant,et al. Breast cancer induction due to mammographic screening in hereditarily affected women. , 1996, Anticancer research.
[96] G. Lenoir,et al. In-situ breast cancer and BRCA 1 , 1996, The Lancet.
[97] W. Thompson,et al. The genetic attributable risk of breast and ovarian cancer , 1996, Cancer.
[98] U. Fischer,et al. Das duktale In-situ-Karzinom in der dynamischen MR-Mammographie bei 1,5 T , 1996 .
[99] C A Kelsey,et al. Benefits versus risks from mammography: A critical reasessment , 1996, Cancer.
[100] P Aspelin,et al. Sensitivity and Specificity of MR Mammography with Histopathological Correlation in 250 Breasts , 1996, Acta radiologica.
[101] R. Fisher,et al. Breast cancer following treatment for Hodgkin's disease: the need for screening in a young population. Australasian Radiation Oncology Lymphoma Group (AROLG) , 1995, Australasian radiology.
[102] K. Helzlsouer,et al. Predictors of and satisfaction with bilateral prophylactic mastectomy. , 1995, Preventive medicine.
[103] M D Schnall,et al. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. , 1995, Radiology.
[104] T. Rebbeck,et al. Assessment and counseling for women with a family history of breast cancer. A guide for clinicians. , 1995, JAMA.
[105] M D Schnall,et al. MR imaging-guided localization and biopsy of breast lesions: initial experience. , 1994, Radiology.
[106] P. Tartter,et al. The significance of family history for patients with carcinoma of the breast. , 1994, Journal of the American College of Surgeons.
[107] N Risch,et al. Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction , 1994, Cancer.
[108] A. Hagenbeek,et al. Second cancer risk following Hodgkin's disease: a 20-year follow-up study. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[109] N. Risch,et al. Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction , 1994 .
[110] C. Steel,et al. Breast cancer survival in BRCA1 carriers , 1993, The Lancet.
[111] N. Risch,et al. Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer. , 1992, American journal of epidemiology.
[112] S. Heywang-Köbrunner,et al. Contrast-Enhanced MRI of the Breast , 1991 .
[113] M. Gail,et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.
[114] S. Heywang,et al. MR imaging of the breast with Gd-DTPA: use and limitations. , 1989, Radiology.
[115] S. Heywang,et al. MR imaging of the breast using gadolinium-DTPA. , 1986, Journal of computer assisted tomography.
[116] S. Heywang,et al. [Nuclear magnetic resonance tomography in breast cancer diagnosis--present status and future outlook]. , 1985, Digitale Bilddiagnostik.
[117] M. Goin,et al. Psychological Reactions to Prophylactic Mastectomy Synchronous with Contralateral Breast Reconstruction , 1982, Plastic and reconstructive surgery.
[118] C E Land,et al. Risk of breast cancer following low-dose radiation exposure. , 1979, Radiology.
[119] J A Koutcher,et al. NMR in cancer. X. A malignancy index to discriminate normal and cancerous tissue , 1978, Cancer.
[120] M. King. Population Genetics of BRCA 1 and BRCA 2 , 2006 .
[121] V. Pennisi,et al. Subcutaneous mastectomy data: A final statistical analysis of 1500 patients , 2005, Aesthetic Plastic Surgery.
[122] Christiane K. Kuhl,et al. Dynamic Breast Magnetic Resonance Imaging , 2005 .
[123] A. Jemal,et al. Cancer Statistics, 2004 , 2004, CA: a cancer journal for clinicians.
[124] D. Venter,et al. The pathology of inherited breast cancer , 2002, Pathology.
[125] J O Barentsz,et al. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. , 2001, Journal of the National Cancer Institute.
[126] Anne,et al. BREAST CANCER AFTER PROPHYLACTIC BILATERAL MASTECTOMY IN WOMEN WITH A BRCA 1 OR BRCA 2 MUTATION , 2001 .
[127] A. Heinig,et al. Interventional MRI of the breast: lesion localisation and biopsy , 2000, European Radiology.
[128] M Oudkerk,et al. MR imaging-guided sonography followed by fine-needle aspiration cytology in occult carcinoma of the breast. , 2000, AJR. American journal of roentgenology.
[129] E. Grabbe,et al. MRI of the breast in patients with metastatic disease of unknown primary , 1999, European Radiology.
[130] J. Law. Cancers detected and induced in mammographic screening: new screening schedules and younger women with family history. , 1997, The British journal of radiology.
[131] A. Schauer,et al. [Ductal carcinoma in situ in dynamic MR-mammography at 1.5 T]. , 1996, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.
[132] A. Ringberg,et al. A prospective study of psychiatric and psychosocial sequelae of bilateral subcutaneous mastectomy. , 1986, Scandinavian journal of plastic and reconstructive surgery.